SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-001088
Filing Date
2018-01-24
Accepted
2018-01-24 17:32:55
Documents
4
Period of Report
2018-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180124_8k.htm 8-K 34338
2 EXHIBIT 99.1 ex_103563.htm EX-99.1 66302
3 a2.jpg GRAPHIC 30453
4 a1.jpg GRAPHIC 9053
  Complete submission text file 0001437749-18-001088.txt   156668
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 18546146
SIC: 2836 Biological Products, (No Diagnostic Substances)